Biotech · Private company · San Diego, CA, US
Reelin Therapeutics, Inc.
Track this companyFree. Adds Reelin Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Identification of next generation gamma-secretase modulators for Alzheimer's diseaseFiscal year 2026 · $241.3KNIH RePORTER 5R41AG094356-02 · fetched Nov 12, 2026
- Identification of next generation gamma-secretase modulators for Alzheimer's diseaseFiscal year 2025 · $258.2KNIH RePORTER 1R41AG094356-01A1 · fetched Nov 12, 2026
- Effect of APP copy number variants in Alzheimer's disease and and Down Syndrome on Reelin expression and functionFiscal year 2024 · $238.5KNIH RePORTER 5R43AG084450-02 · fetched Nov 12, 2026